GLP-1R agonists are not a quick fix for weight loss

Weight loss also increased with dose. [...]some of the weight loss could be because patients receiving the drug felt too ill to continue their normal eating habits rather than because of the drug's actions on insulin and glucagon. Effects of glucagon-like peptide-1 receptor agonists on weight l...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 2012-02, Vol.344 (feb28 2), p.e1455; author reply e1459-e1455
1. Verfasser:	Iverson, Kristen A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Obesity Agents - therapeutic use Diabetes Drug dosages Glucagon-Like Peptide 1 - analogs & derivatives Humans Hypoglycemic Agents - therapeutic use Overweight - drug therapy Peptides - therapeutic use Receptors, Glucagon - agonists Venoms - therapeutic use Weight control Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Weight loss also increased with dose. [...]some of the weight loss could be because patients receiving the drug felt too ill to continue their normal eating habits rather than because of the drug's actions on insulin and glucagon. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
ISSN:	0959-8138 1468-5833 1756-1833
DOI:	10.1136/bmj.e1455